New math model controls biological noise at single-cell level, offering a path to tackle cancer relapse and drug resistance.

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it received notice from the U.S. Food and Drug ...

For decades, cancer patients have been told that shrinking tumors meant accepting brutal side effects as the price of ...

The fundraiser for a 14-year-old Corby boy diagnosed with an aggressive brain tumour is nearing its £250k target thanks to ...

Verastem, Inc. shifts focus to VS-7375 for KRAS G12D tumors after ending RAMP-203. Click to learn about VSTM's key catalysts ...

A large-scale study by Chinese researchers offers a new treatment path for patients with the most aggressive form of breast ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

Oncology nurses and APPs are key players in patient education on precision medicine.

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

Tongue cancer (TC) cells can enter a chemo-resistant state by activating pathways related to autophagy and cholesterol synthesis, report researchers from Institute of Science Tokyo. Using a ...